MedPath

OmniAb

🇺🇸United States
Ownership
-
Employees
106
Market Cap
$509.2M
Website
Introduction

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

© Copyright 2025. All Rights Reserved by MedPath